Prima Mente
Antler 2023 · CFDX aims to apply the liquid biopsy techniques used in early cancer detection to neurodegenerative diseases, enabling diagnosis decades before symptoms appear.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Not stated | Antler2023 | |
| Other | Not stated | Plug and Play | |
| Other | Not stated | Plug and Play | |
| Other | Not stated | Plug and Play | |
| Other | Not stated | Plug and Play |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Not stated | EF2016 | |
| Other | Not stated | Antler +12024 | |
| Other | Not stated | Antler2020 | |
| AI | Not stated | Antler2025 | |
| Other | Inactive | YCS14 |
Also from Antler 2023
All of Antler 2023Programs
| Program | Cohort | Source |
|---|---|---|
| 2023 | Antler Page |
About Prima Mente
- Category
- Other
- Location
- UK
- Checked
- 3h ago
Tags: Health and BioTech
Prima Mente: questions
Which accelerators did Prima Mente go through?
Prima Mente is listed by Antler (2023).
Where is Prima Mente based?
Prima Mente lists UK as its location on Antler's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.